Melbourne Researchers Make Significant Progress Toward HIV Cure Using mRNA Technology
Researchers at Melbourne's Doherty Institute have developed a pioneering mRNA-based method to target and activate dormant HIV reservoirs, potentially paving the way for a cure. This 'shock and kill' strategy uses lipid nanoparticles to deliver instructions to wake the virus, allowing it to be targeted and destroyed, and represents a significant breakthrough in HIV treatment research. The approach is still in early testing stages, with animal trials planned before human trials, but it leverages the same technology used in COVID-19 vaccines, promising scalable and accessible solutions in the future.